Review Article

Year : 2019 | Volume : 3 | Issue : 2 | Page : 41 - 43

Myeloid sarcoma

S. Saivignesh, M. P. Brundha1

Departments of Pathology and 1 General Pathology, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Science, Chennai, Tamil Nadu, India

Address for correspondence:

Dr. M. P. Brundha, Department of General Pathology, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Science, 162, Poonamalle High Road, Velapanchavadi, Chennai ‐ 600 077, Tamil Nadu, India.

E‐mail: generalpath2015@gmail.com

Abstract

Myeloid sarcoma is an extramedullary tumor of immature granulocytic cells. It is usually accompanied by acute myeloid leukemia, although in some rare cases, it may present in nonleukemic patients. It is a rare entity characterized by the occurrence of one or more tumor myeloid masses occurring at an extramedullary site. It may occur at any site, leading to very varied clinical presentations. However, the most common locations are soft tissues, bone, peritoneum, and lymph nodes. The aim of this review is to summarize about pathogenesis, diagnostic test, prognosis, and treatment of myeloid sarcoma.

Keywords: Bone, granulocytic cells, lymph nodes, medullary tumor, pathogenesis

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

How to cite this article:

Saivignesh S, Brundha MP. Myeloid sarcoma. Int J Clinicopathol Correl 2019;3:41-3.